secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0001193125-25-091357
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q3 FY2025: revenue $1.29B (+8%), GAAP EPS $2.48 (+22%), non-GAAP EPS $2.37 (+11%)
--------------------------------------------------------------------------------

- Revenue of $1.29B (+8% YoY; +9% constant currency); GAAP diluted EPS $2.48 vs $2.04 (+22%).
- Gross margin improved 140 bps to 59.3%; non-GAAP gross margin 59.9%.
- Operating income up 14% to $426.3M; non-GAAP operating income up 13% to $444.6M.
- Operating cash flow of $579M in the quarter.
- Quarterly dividend of $0.53/share declared; payable June 12, 2025 to holders of record May 8, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312525091357/0001193125-25-091357-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312525091357/d830100d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-091357

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer